Doptelet 20 mg tablet is a prescription medicine containing Avatrombopag for oral use, marketed by AkaRx, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store DOPTELET tablets at room temperature from 20°C to 25°C (68°F to 77°F)…
Key facts
- Active ingredient (INN)
- Avatrombopag
- Brand
- Doptelet
- Strength
- 20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 blister pack, 2 blister pack
- Marketing authorisation holder
- AkaRx
- Manufacturer
- AkaRx
- Origin register
- US FDA, United States
- Storage
- Store DOPTELET tablets at room temperature from 20°C to 25°C (68°F to 77°F), excursions permitted from 15°C to 30°C (59°F to 86°F). How Supplied Carton and Bottle NDC Carton with one bottle of 30 capsules (containing oral granules) NDC 71369-010-30 Store DOPTELET SPRINKLE capsules at room temperature from 20°C to 25°C (68°F to 77°F), excursions permitted from 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B02BX08 Avatrombopag
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 May 2018
- Identifiers
- RxCUI 2045951, 2045952, 2045958 +5DailyMed set ID e2d5960d-6c18-46cc-86bd-089222b09852NDC 71369-020Application NDA210238
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 71369-020-10 | AkaRx | 23 May 2018 |
| 1 blister pack in 1 carton / 15 tablet, film coated in 1 blister pack | 71369-020-15 | AkaRx | 23 May 2018 |
| 2 blister pack in 1 carton / 15 tablet, film coated in 1 blister pack | 71369-020-30 | AkaRx | 26 June 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Avatrombopag
Clinical summary
Avatrombopag is a prescription medicine indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure, among other approved uses. MedsAcross supplies Avatrombopag for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AvatrombopagFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Doptelet Sprinkle prescribing information (AkaRx) · U.S. National Library of Medicine, DailyMed
- Doptelet: European public assessment report (EPAR) · European Medicines Agency
Need Doptelet 20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.